Halozyme Therapeutics Inc (HALO)

Exchange
NASDAQ
Symbol
HALO
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California.
Country
USA

Stock price

At close: May 7, 2025

  • Open
    63.69
  • High
    70.51
  • Low
    61.75
  • Close
    70.14
  • Volume
    9,681,940

Financial ratios

Dec 31, 2024